Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site
- PMID: 2334433
- DOI: 10.1016/0006-291x(90)92380-i
Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site
Abstract
The functions associated with the inhibitory region and calmodulin binding region of smooth muscle myosin light chain kinase (MLCK) were studied using various synthetic peptide analogs. Peptides 480-501 and 483-498 strongly inhibited 61 kDa Ca2+/calmodulin-independent MLCK activity with Ki of 25 nM. Peptides 493-512 and 493-504 were considerably less effective as inhibitor of the Ca2+/calmodulin-independent MLCK and Kiapp. were 2 and 3 microM, respectively. Inhibition of Ca2+/calmodulin-independent MLCK by the peptides 480-501 and 483-498 were competitive with ATP and 20,000 dalton smooth muscle myosin light chain. The inhibition of native MLCK by peptide 493-512 was explained by the calmodulin depletion model in which the peptide binds to free calmodulin and prevents it from activating MLCK. On the other hand, the inhibition of native MLCK by the peptides 480-501 and 483-498 was explained by the binding of these peptides to the MLCK-calmodulin complex. The present study suggests that the inhibitory region of MLCK directly binds to MLCK active site and competes with both ATP and 20,000 dalton light chain so as to inhibit the enzyme.
Similar articles
-
Affinity labelling of smooth-muscle myosin light-chain kinase with 5'-[p-(fluorosulphonyl)benzoyl]adenosine.Biochem J. 1993 Nov 15;296 ( Pt 1)(Pt 1):53-8. doi: 10.1042/bj2960053. Biochem J. 1993. PMID: 8250857 Free PMC article.
-
Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.Biochem J. 1991 May 1;275 ( Pt 3)(Pt 3):679-84. doi: 10.1042/bj2750679. Biochem J. 1991. PMID: 1710106 Free PMC article.
-
Peptide modulators of myosin light chain kinase affect smooth muscle cell contraction.Am J Physiol. 1990 Aug;259(2 Pt 1):C315-24. doi: 10.1152/ajpcell.1990.259.2.C315. Am J Physiol. 1990. PMID: 2116724
-
Regulation of smooth muscle myosin light chain kinase by calmodulin.Adv Exp Med Biol. 1991;304:11-24. doi: 10.1007/978-1-4684-6003-2_3. Adv Exp Med Biol. 1991. PMID: 1803894 Review.
-
Biochemistry of smooth muscle myosin light chain kinase.Arch Biochem Biophys. 2011 Jun 15;510(2):135-46. doi: 10.1016/j.abb.2011.04.018. Epub 2011 May 3. Arch Biochem Biophys. 2011. PMID: 21565153 Free PMC article. Review.
Cited by
-
Vascular smooth muscle contractile elements. Cellular regulation.Hypertension. 1991 Jun;17(6 Pt 1):723-32. doi: 10.1161/01.hyp.17.6.723. Hypertension. 1991. PMID: 2045132 Free PMC article. Review.
-
Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells.Br J Pharmacol. 2007 Sep;152(1):122-31. doi: 10.1038/sj.bjp.0707368. Epub 2007 Jul 2. Br J Pharmacol. 2007. PMID: 17603544 Free PMC article.
-
Affinity labelling of smooth-muscle myosin light-chain kinase with 5'-[p-(fluorosulphonyl)benzoyl]adenosine.Biochem J. 1993 Nov 15;296 ( Pt 1)(Pt 1):53-8. doi: 10.1042/bj2960053. Biochem J. 1993. PMID: 8250857 Free PMC article.
-
Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.Biochem J. 1991 May 1;275 ( Pt 3)(Pt 3):679-84. doi: 10.1042/bj2750679. Biochem J. 1991. PMID: 1710106 Free PMC article.
-
Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.Pharm Res. 2008 Jun;25(6):1377-86. doi: 10.1007/s11095-007-9527-6. Pharm Res. 2008. PMID: 18163202
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous